Shenzhen Children's Hospital
π¨π³China
Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 4
1 (50.0%)Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases
Phase 4
- Conditions
- Convulsive Diseases
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2008-11-24
- Lead Sponsor
- Shenzhen Children's Hospital
- Target Recruit Count
- 1
- Registration Number
- NCT00796380
News
Novel Selenium-Enhanced Exosome Therapy Shows Promise for Traumatic CNS Injuries
Researchers from the Chinese Academy of Sciences developed SeNExo, a novel therapeutic agent combining neural stem cell-derived exosomes with ultrasmall nano-selenium particles for treating traumatic brain and spinal cord injuries.